News

August 7, 2019 - Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation Read More

September 17, 2019 - CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019 Read More

September 10, 2019 - Sotera Spoltight – Meet Devin McCombie, PhD, CSO Read More

September 4, 2019 - Visi Mobile Remote Viewing Display (RVD) Read More

August 13, 2019 - ViSi Mobile Detects Many Types of Patient Deterioration Read More

August 12, 2019 - Asteres ScriptCenter Products now on ECAT Read More

August 6, 2019 - Learn about ViSi Mobile 1.5G and see it in action! Read More

July 24, 2019 - ViaCyte to Expand Board of Directors with Two New Appointments Read More

July 23, 2019 - Continuous Surveillance Monitoring: the Standard of Care Read More

July 9, 2019 - Vital Signs Workflow — The ViSi difference Read More